APPLEDOWN CLINICAL RESEARCH LIMITED

🌳Matureactive
03886155 · ltd · incorporated 1999-11-30
Investment thesis
Well-run mature business — low negotiation leverage; premium likely.
Why interesting: Textbook target; clean filings, stable trading.
Why risky: No pressure on seller; any deal likely at full price.
Opportunity decay
hardening · 12-months
Already tight — no obvious softening catalysts on the horizon.
  • · Thesis: well-run, low negotiation leverage
🔒Estimated value
Upgrade to see
Turnover
year to Mar 2025
Net worth
book net assets
Opportunity
80/100
Exceptional
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Other research and experimental development on natural sciences and engineering
Sector: Professional, scientific & technical
Investor take
Pursue
Active trading company with a 64-year-old founder — textbook succession opportunity.

Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (70/100, director aged 64). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).

Data confidence

Overall: medium (76/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
5 officers (3 active, 5 linked, 2 with DOB)
78
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
Network not yet resolved
30
Filing history
77 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
80/100Exceptional
PassWatchWorth a lookStrongExceptional 

Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
80
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0Mar 2024Mar 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2025-03-312024-03-31
Average employees200200

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
0
filings
Counts from Companies House filing history.
Corporate timeline (23 events)Click to expand
  1. 2025-07-15
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  2. 2024-06-04
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  3. 2023-05-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  4. 2022-06-10
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  5. 2022-01-31
    📄
    change-person-director-company-with-change-date
    officers · CH01
  6. 2022-01-31
    📄
    change-person-director-company-with-change-date
    officers · CH01
  7. 2022-01-31
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  8. 2022-01-31
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  9. 2022-01-31
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  10. 2021-07-01
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  11. 2020-06-02
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  12. 2019-12-20
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  13. 2018-11-26
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  14. 2017-09-13
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  15. 2016-11-17
    📄
    accounts-with-accounts-type-total-exemption-small
    accounts · AA
  16. 1999-12-20
    MCKENNA, David appointed
    director
  17. 1999-11-30
    🏢
    Company incorporated
    As APPLEDOWN CLINICAL RESEARCH LIMITED
  18. 1999-11-30
    MCKENNA, David appointed
    secretary
  19. 1999-11-30
    MCKENNA, Ceri Jean appointed
    director
  20. 1999-11-30
    BRITANNIA COMPANY FORMATIONS LIMITED appointed
    corporate-nominee-secretary
  21. 1999-11-30
    BRITANNIA COMPANY FORMATIONS LIMITED resigned
    corporate-nominee-secretary
  22. 1999-11-30
    DEANSGATE COMPANY FORMATIONS LIMITED appointed
    corporate-nominee-director
  23. 1999-11-30
    DEANSGATE COMPANY FORMATIONS LIMITED resigned
    corporate-nominee-director

Owner dependency

84/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Long-tenure founder: Senior director has been in place 27 years — deep operational knowledge concentrated in one person.
  • +Senior director age: Director aged approximately 64 — approaching natural succession window.
  • +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.

Succession & seller-readiness

86/100
Likely off-market candidate

Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.

SIGNALS
  • primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
  • primary20+ year tenure: Director in role 27 years. Very long tenure is a classic succession signal.
  • secondaryStable-but-static management: Company is 27 years old and no new directors in the last 3 years — succession not yet being planned internally.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Mrs Ceri Jean Mckenna
Individual · British · DOB 03/1963 · age 63
5075%
50-75% shares06/04/2016
Mr David Mckenna
Individual · British · DOB 08/1962 · age 64
2550%
25-50% shares06/04/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Professional services · SL postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
ALOIS TECHNOLOGIES LIMITED
10621417 · est 2017 · no financials extracted
9y
ANDY ZMH LTD
16811942 · est 2025 · no financials extracted
ANGLO AUSTRIAN LIMITED
12980013 · est 2020 · no financials extracted
5y
ANJA BIO LTD
14841576 · est 2023 · no financials extracted
2y
ANTROBUS SOLUTIONS LIMITED
11755491 · est 2019 · no financials extracted
7y
ANUSHIA REDDY LIMITED
10274045 · est 2016 · no financials extracted
9y
APEX SALES PERFORMANCE LTD
16172747 · est 2025 · no financials extracted
1y
APPLIED LEGAL SERVICES LIMITED
10720275 · est 2017 · no financials extracted
9y
APPRENTICESHIP SOLUTIONS LIMITED
07771979 · est 2011 · no financials extracted
14y
AR CONSULTANCY LONDON LTD
14151309 · est 2022 · no financials extracted
3y
ARAB ISLAMIC NATIONAL MOVEMENT LIMITED
16181834 · est 2025 · no financials extracted
1y
ARAUCARIA PARTNERS LTD
15695125 · est 2024 · no financials extracted
1y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated1999-11-30
Jurisdictionengland-wales
Primary SIC72190 — Other research and experimental development on natural sciences and engineering

Registered office

Fawley House 2 Regatta Place
Marlow Road
Bourne End
Buckinghamshire
SL8 5TD
United Kingdom

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2026-12-14
Last: 2025-11-30

Officers (3 active · 2 resigned)

MCKENNA, David
secretary · appointed 1999-11-30
View their other companies + combined net worth →
Active
MCKENNA, Ceri Jean
director · ~63y · appointed 1999-11-30
View their other companies + combined net worth →
Active
MCKENNA, David
director · ~64y · appointed 1999-12-20
View their other companies + combined net worth →
Active
BRITANNIA COMPANY FORMATIONS LIMITED
corporate-nominee-secretary · appointed 1999-11-30 · resigned 1999-11-30
Resigned
DEANSGATE COMPANY FORMATIONS LIMITED
corporate-nominee-director · appointed 1999-11-30 · resigned 1999-11-30
Resigned

Click a director name to see their full track record across all companies.

Recent filings (77 total)

confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-12-17
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-07-15
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-12-12
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-06-04
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-12-14
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-05-31
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-12-14
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-06-10
change-person-director-company-with-change-date
officers · CH01
2022-01-31
change-person-director-company-with-change-date
officers · CH01
2022-01-31
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2022-01-31
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2022-01-31
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2022-01-31
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-12-15
accounts-with-accounts-type-total-exemption-full
accounts · AA
2021-07-01